Q3 2022 Aptose Biosciences Inc Earnings Call Transcript
Good afternoon. My name is [Shandrelin], and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences conference call for the third quarter ending September 30, 2022. (Operator Instructions) As a reminder, this conference call is being recorded.
And I would like to take this time to introduce Ms. Susan Pietropaolo. Susan?
Thank you, [Shandrelin]. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the third quarter ended September 30, 2022. Earlier today, Aptose issued a press release relating to these financial results. The news release, as well as related SEC filings are accessible on Aptose's website. Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO and Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer and Mr. Fletcher Payne, Senior Vice President and Chief Financial Officer.
Before we proceed, I would like to remind everyone
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |